STANDARD BIOTOOLS INC. - COMMON STOCK

Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion

01 أبريل 2022 13:05:00 بحسب Nasdaq GlobeNewswire

Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global

29 مارس 2022 06:29:06 بحسب Nasdaq GlobeNewswire

Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution

28 مارس 2022 05:30:00 بحسب Nasdaq GlobeNewswire

Fluidigm Adjourns Special Meeting of Stockholders Until April 1, 2022

25 مارس 2022 13:00:00 بحسب Nasdaq GlobeNewswire

Fluidigm Urges Stockholders to Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion TODAY

21 مارس 2022 05:00:01 بحسب Nasdaq GlobeNewswire

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Fluidigm Stockholders Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion

17 مارس 2022 14:58:32 بحسب Nasdaq GlobeNewswire

Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results 

17 فبراير 2022 14:43:00 بحسب Nasdaq GlobeNewswire

Fluidigm Announces Collaboration Agreement with the Abu Dhabi Stem Cells Center to Accelerate Imaging Mass Cytometry in Development of Targeted Stem Cell Therapies

17 فبراير 2022 05:30:01 بحسب Nasdaq GlobeNewswire

Fluidigm Files Preliminary Proxy Statement in Connection with Proposed Strategic Capital Infusion from Casdin Capital and Viking Global Investors

14 فبراير 2022 03:10:00 بحسب Nasdaq GlobeNewswire

Fluidigm Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc.

24 يناير 2022 05:30:01 بحسب Nasdaq GlobeNewswire

Fluidigm Announces Preliminary Revenue Exceeding Guidance for the Fourth Quarter and Full Year 2021

11 يناير 2022 05:00:01 بحسب Nasdaq GlobeNewswire

Fluidigm Confirms Advanta Dx SARS-CoV-2 RT-PCR Assay on the Company’s Biomark Platform Detects Omicron Variant of COVID-19

07 ديسمبر 2021 05:30:00 بحسب Nasdaq GlobeNewswire

Fluidigm to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

16 نوفمبر 2021 05:30:00 بحسب Nasdaq GlobeNewswire

Biomark X Offers Industry-Leading Advantages in Speed, Throughput, Flexibility and Cost

11 نوفمبر 2021 05:30:00 بحسب Nasdaq GlobeNewswire

Fluidigm Announces Third Quarter 2021 Financial Results

08 نوفمبر 2021 13:02:00 بحسب Nasdaq GlobeNewswire

Imaging Mass Cytometry Utilized to Seek Molecular Links between African Ancestry and Aggressive Forms of Breast and Prostate Cancer

08 نوفمبر 2021 05:30:01 بحسب Nasdaq GlobeNewswire

Fluidigm Announces Conference Call and Webcast of Third Quarter 2021 Financial Results

20 أكتوبر 2021 05:30:00 بحسب Nasdaq GlobeNewswire

Fluidigm 2021 IMC Summit Focuses on ‘Uncovering Spatial Biology’

18 أكتوبر 2021 05:30:00 بحسب Nasdaq GlobeNewswire

Fluidigm Announces New Co-Marketing Program under Collaboration Agreement with Visiopharm, Offering AI-Based Image Analysis Software

12 أكتوبر 2021 05:30:00 بحسب Nasdaq GlobeNewswire

Fluidigm Announces Collaboration Agreement with Karolinska Institutet to Accelerate Customer Adoption of New CyTOF XT

28 سبتمبر 2021 05:30:00 بحسب Nasdaq GlobeNewswire